Home » Topics » Regulatory » Patents

Patents
RSS

Bionomics discloses new agents for CNS disorders

Sep. 20, 2012

Japanese researchers present novel GPR119 receptor agonists

Sep. 20, 2012

New ghrelin receptor antagonists disclosed by Helsinn Healthcare

Sep. 19, 2012

Japanese scientists synthesize novel agents for thromboembolic disorders

Sep. 19, 2012

Eternity Biosciences prepares new protein kinase inhibitors

Sep. 19, 2012

Suven Life Sciences discloses new H3 receptor ligands

Sep. 19, 2012

Astellas Pharma presents novel antifungal agents

Sep. 19, 2012

Canadian and U.S. group patents new antibacterial agents

Sep. 19, 2012

Novel nicotinic acetylcholine alpha7 receptor modulators disclosed by Lupin

Sep. 18, 2012

Janssen Pharmaceutica patents new alpha7 receptor modulators

Sep. 18, 2012

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...